GSK drug fails to hit goal in breast cancer trial
 |
| Signage is pictured on the company headquarters of GlaxoSmithKline in west London |
LONDON (Reuters) - GlaxoSmithKline's drug Tykerb failed to hit its goal in a clinical trial testing its role in women with early breast cancer, dimming hopes for its use in this setting. Britain's biggest drugmaker said results from a Phase III study of Tykerb given in the delayed adjuvant setting, following initial surgery or chemotherapy, did not reach statistical significance. The findings from the so-called TEACH study were presented late on Thursday at the San Antonio Breast Cancer Symposium. ... read more..
source:http://yhoo.it/sQOzb2
No comments:
Post a Comment